Serum migration inhibitory activity in patients with posttransplantation hepatic dysfunction.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D002464:Cell Migration Inhibition; D006511:Hepatitis B Antigens / Q000032:analysis; D006736:Horses / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008107:Liver Diseases / Q000209:etiology / Q000276:immunology*; D008111:Liver Function Tests; D016031:Liver Transplantation; D008263:Macrophage Migration-Inhibitory Factors; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D006511:Hepatitis B Antigens; D008263:Macrophage Migration-Inhibitory Factors; D001219:Aspartate Aminotransferases; D001379:Azathioprine; D011241:Prednisone